U.S. flag

An official website of the United States government

NM_002109.6(HARS1):c.679T>G (p.Ser227Ala) AND not specified

Germline classification:
Conflicting interpretations of pathogenicity (2 submissions)
Last evaluated:
Oct 19, 2020
Review status:
criteria provided, conflicting classifications
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001000572.9

Allele description [Variation Report for NM_002109.6(HARS1):c.679T>G (p.Ser227Ala)]

NM_002109.6(HARS1):c.679T>G (p.Ser227Ala)

Gene:
HARS1:histidyl-tRNA synthetase 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
5q31.3
Genomic location:
Preferred name:
NM_002109.6(HARS1):c.679T>G (p.Ser227Ala)
HGVS:
  • NC_000005.10:g.140677705A>C
  • NG_032158.1:g.18682T>G
  • NM_001258040.3:c.559T>G
  • NM_001258041.3:c.619T>G
  • NM_001258042.3:c.499T>G
  • NM_001289092.2:c.457T>G
  • NM_001289093.2:c.337T>G
  • NM_001289094.2:c.592T>G
  • NM_002109.6:c.679T>GMANE SELECT
  • NP_001244969.1:p.Ser187Ala
  • NP_001244970.1:p.Ser207Ala
  • NP_001244971.1:p.Ser167Ala
  • NP_001276021.1:p.Ser153Ala
  • NP_001276022.1:p.Ser113Ala
  • NP_001276023.1:p.Ser198Ala
  • NP_002100.2:p.Ser227Ala
  • LRG_1374t1:c.679T>G
  • LRG_1374:g.18682T>G
  • LRG_1374p1:p.Ser227Ala
  • NC_000005.9:g.140057290A>C
  • NM_002109.3:c.679T>G
  • NM_002109.5:c.679T>G
Protein change:
S113A
Links:
dbSNP: rs768076848
NCBI 1000 Genomes Browser:
rs768076848
Molecular consequence:
  • NM_001258040.3:c.559T>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001258041.3:c.619T>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001258042.3:c.499T>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001289092.2:c.457T>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001289093.2:c.337T>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001289094.2:c.592T>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_002109.6:c.679T>G - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:
AllHighlyPenetrant
Identifiers:
MedGen: CN169374

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001157536ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
criteria provided, single submitter

(ARUP Molecular Germline Variant Investigation Process)
Uncertain significance
(Jun 17, 2019)
germlineclinical testing

Citation Link,

SCV002755232Ambry Genetics
criteria provided, single submitter

(Ambry Variant Classification Scheme 2023)
Likely benign
(Oct 19, 2020)
germlineclinical testing

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Details of each submission

From ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories, SCV001157536.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

The HARS c.679T>G; p.Ser227Ala variant has been reported once in a CMT patient who carried a second variant of the same gene (Lupo 2016). This variant is listed in the Genome Aggregation Database (gnomAD) with a frequency of 0.09 percent in the Latino population (identified on 31 out of 35,428 chromosomes) and has been reported to the ClinVar database (ClinVar ID: 576600). The serine at position 227 is weakly conserved and computational analyses of the effects of the p.Ser227Ala variant on protein structure and function is conflicting (SIFT: damaging, PolyPhen-2: benign). Altogether, there is not enough evidence to classify the p.Ser227Ala variant with certainty.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Ambry Genetics, SCV002755232.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: May 26, 2024